APA (7th ed.) Citation

Canepari, C., Milani, M., Starinieri, F., Fabiano, A., Russo, F., Norata, R., . . . Cantore, A. (2024). Low-density lipoproteins receptor (LDLR) liver gene therapy normalizes LDL cholesterol (LDL-C) and prevents atherosclerosis in a familial hypercholesterolemia (FH) mouse model. Atherosclerosis, 395, 118281. https://doi.org/10.1016/j.atherosclerosis.2024.118281

Chicago Style (17th ed.) Citation

Canepari, Cesare, et al. "Low-density Lipoproteins Receptor (LDLR) Liver Gene Therapy Normalizes LDL Cholesterol (LDL-C) and Prevents Atherosclerosis in a Familial Hypercholesterolemia (FH) Mouse Model." Atherosclerosis 395 (2024): 118281. https://doi.org/10.1016/j.atherosclerosis.2024.118281.

MLA (9th ed.) Citation

Canepari, Cesare, et al. "Low-density Lipoproteins Receptor (LDLR) Liver Gene Therapy Normalizes LDL Cholesterol (LDL-C) and Prevents Atherosclerosis in a Familial Hypercholesterolemia (FH) Mouse Model." Atherosclerosis, vol. 395, 2024, p. 118281, https://doi.org/10.1016/j.atherosclerosis.2024.118281.